Christophe Roberge

Christophe Roberge is the Chief Technical Officer at MedinCell. Christophe has over 14 years of experience with the company and has held various titles, including Partnering Director, Senior Expert Science & Technology, and Senior Technology Advisor. In their current role, Christophe is responsible for defining the strategic orientations in the Research & Development unit, scouting technologies, maximizing the IP protection, and supporting the Business Development work.

Prior to their current role, Christophe was the Director of Process Development & Industrialization for BioArtificial Gel Technologies. In this role, they were responsible for process scale-up and validation, design of cGMP compliant process equipment, and pilot/engineering batch supervision. Christophe also led the design and engineering support for the building and starting of a cGMP-compliant facility for the aseptic manufacturing of medical devices (hydrogel-based wound dressing).

Christophe Roberge has a PhD in biomaterials and polymer science from the Université du Québec - Institut national de la recherche scientifique.

The team of Christophe Roberge is composed of the following people: David Heuzé, Joël Richard, Quiterie De Beauregard, Sébastien Enault, Jaime Arango, Adolfo Lopez Noriega, Helen Martin, Christophe Roberge, and Franck Pouzache.